{"nct_id":"NCT00920140","title":"Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias","status":"COMPLETED","status_verified_date":"2014-03","start_date":"2011-05","start_date_type":null,"primary_completion_date":"2013-04","primary_completion_date_type":"ACTUAL","completion_date":"2013-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}